B Marroquin1, C Feng2, A Balofsky2, K Edwards2, A Iqbal2, J Kanel2, M Jackson3, M Newton3, D Rothstein2, E Wong2, R Wissler2. 1. Department of Anesthesiology, University of Rochester Medical Center, Rochester, NY, USA. Electronic address: bridget.marroquin@uvmhealth.org. 2. Department of Anesthesiology, University of Rochester Medical Center, Rochester, NY, USA. 3. University of Rochester College of Medicine, Rochester, NY, USA.
Abstract
BACKGROUND: Cesarean delivery is the most common surgical procedure performed in the USA. We evaluated the postoperative analgesic properties of neuraxial hydromorphone compared to neuraxial morphine for post-cesarean delivery analgesia. METHODS: A retrospective chart review was performed of women who underwent cesarean delivery and received neuraxial anesthesia from March to November 2011 and from March to November 2012. A total of 450 patients received intrathecal morphine 200μg and 387 patients received intrathecal hydromorphone 60μg. Eighty-one patients received epidural morphine 3mg and 102 patients received epidural hydromorphone 0.6mg. RESULTS: Median time to first opioid after intrathecal morphine was 17.0h versus 14.6h after intrathecal hydromorphone (P<0.0001). Patients who received intrathecal hydromorphone consumed more opioids in the first 24h; 37.0mg versus 26.4mg oral morphine equivalents (P<0.001). The side effect profile between the intrathecal groups was similar. Median time to first opioid with epidural morphine was 20.1h versus 13.0h with epidural hydromorphone (P=0.0007). Total opioid consumption was not significantly different between the epidural groups. The side effect profiles were similar. CONCLUSIONS: Hydromorphone is a reasonable alternative to morphine for post-cesarean delivery analgesia. With the dosing used in our study, analgesia from morphine lasted longer than hydromorphone via intrathecal and epidural routes; however, neuraxial hydromorphone remains a reasonable option for long-acting analgesia post cesarean delivery.
BACKGROUND: Cesarean delivery is the most common surgical procedure performed in the USA. We evaluated the postoperative analgesic properties of neuraxial hydromorphone compared to neuraxial morphine for post-cesarean delivery analgesia. METHODS: A retrospective chart review was performed of women who underwent cesarean delivery and received neuraxial anesthesia from March to November 2011 and from March to November 2012. A total of 450 patients received intrathecal morphine 200μg and 387 patients received intrathecal hydromorphone 60μg. Eighty-one patients received epidural morphine 3mg and 102 patients received epidural hydromorphone 0.6mg. RESULTS: Median time to first opioid after intrathecal morphine was 17.0h versus 14.6h after intrathecal hydromorphone (P<0.0001). Patients who received intrathecal hydromorphone consumed more opioids in the first 24h; 37.0mg versus 26.4mg oral morphine equivalents (P<0.001). The side effect profile between the intrathecal groups was similar. Median time to first opioid with epidural morphine was 20.1h versus 13.0h with epidural hydromorphone (P=0.0007). Total opioid consumption was not significantly different between the epidural groups. The side effect profiles were similar. CONCLUSIONS:Hydromorphone is a reasonable alternative to morphine for post-cesarean delivery analgesia. With the dosing used in our study, analgesia from morphine lasted longer than hydromorphone via intrathecal and epidural routes; however, neuraxial hydromorphone remains a reasonable option for long-acting analgesia post cesarean delivery.
Authors: Emily E Sharpe; Rochelle J Molitor; Katherine W Arendt; Vanessa E Torbenson; David A Olsen; Rebecca L Johnson; Darrell R Schroeder; Adam K Jacob; Adam D Niesen; Hans P Sviggum Journal: Anesthesiology Date: 2020-06 Impact factor: 7.892
Authors: Mellany A Stanislaus; Joseph L Reno; Robert H Small; Julie H Coffman; Mona Prasad; Avery M Meyer; Kristen M Carpenter; John C Coffman Journal: J Pain Res Date: 2020-04-28 Impact factor: 3.133